Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
BJR Case Reports|October 27, 2018
Organizing pneumonia after pancreatic cancer treatment with nab-paclitaxel and gemcitabine: a case reportFrancesca Comito, Elisa Grassi, Antonio Poerio, et al.Melanoma Research|August 30, 2022
Clinical characteristics and treatment outcomes of non-V600 E/K BRAF mutant melanoma patients: a single-institution experienceFrancesca Comito, Marta Aprile, Rachele Pagani, et al.Therapeutic Advances in Urology|February 14, 2018
Circulating tumor cells in genitourinary tumorsFrancesco Massari, Vincenzo Di Nunno, Francesca Comito, et al.Cancer Treatment Reviews|October 10, 2017
Adjuvant therapy in renal cell carcinomaFrancesco Massari, Vincenzo Di Nunno, Chiara Ciccarese, et al.Archives of Dermatological Research|December 6, 2024
Defining high-risk patients: beyond the 8the AJCC melanoma staging systemElisabetta Broseghini, Giulia Veronesi, Aldo Gardini, et al.Current Oncology (Toronto, Ont.)|December 24, 2025
Should Fertility Preservation Be Offered to Young Women with Melanoma Receiving Immune Checkpoint Inhibitors? A SWOT AnalysisDiego Raimondo, Michele Miscia, Antonio Raffone, et al.Plos One|August 1, 2015
Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-AnalysisBruno Vincenzi, Massimo Di Maio, Marianna Silletta, et al.Diagnostics (Basel, Switzerland)|April 26, 2024
Molecular Characterization of Advanced-Stage Melanomas in Clinical Practice Using a Laboratory-Developed Next-Generation Sequencing PanelThais Maloberti, Antonio De Leo, Sara Coluccelli, et al.International Journal of Oncology|April 6, 2018
Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosisElisa Grassi, Sandra Durante, Annalisa Astolfi, et al.Journal of Neurology|February 17, 2023
Peripheral nervous system adverse events associated with immune checkpoint inhibitorsSimone Rossi, Francesco Gelsomino, Rita Rinaldi, et al.Pageof 3